The aim of the study is to determine the penetration levels of ertapenem into bone tissues in
patients with Diabetes Mellitus (D.M) or Peripheral Vascular Diseases (P.V.D) undergoing
amputation, and to correlate theme to the concentration of the drug in blood and other soft
tissues